Macrocyclic hepatitis C serine protease inhibitors
The present invention relates to novel macrocyclic compounds and methods of treating a hepatitis C infection in a subject in need of such therapy with said macrocyclic compounds. The present invention further relates to pharmaceutical compositions comprising the compounds of the present invention, o...
Saved in:
Main Authors | , , , , , , , , , , , , , , |
---|---|
Format | Patent |
Language | English |
Published |
10.06.2010
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | The present invention relates to novel macrocyclic compounds and methods of treating a hepatitis C infection in a subject in need of such therapy with said macrocyclic compounds. The present invention further relates to pharmaceutical compositions comprising the compounds of the present invention, or pharmaceutically acceptable salts, esters, or prodrugs thereof, in combination with a pharmaceutically acceptable carrier or excipient. |
---|---|
AbstractList | The present invention relates to novel macrocyclic compounds and methods of treating a hepatitis C infection in a subject in need of such therapy with said macrocyclic compounds. The present invention further relates to pharmaceutical compositions comprising the compounds of the present invention, or pharmaceutically acceptable salts, esters, or prodrugs thereof, in combination with a pharmaceutically acceptable carrier or excipient. |
Author | WAGAW SEBLE H LIU DONG MEI JIANZHANG SUN YING CHEN HUI-JU MCDANIEL KEITH F SHANLEY JASON P KEMPF DALE J KU YIYIN GAI YONGHUA GRIEME TIM GRAMPOVNIK DAVID J OR YAT SUN SHEIKH AHMAD ENGSTROM KEN |
Author_xml | – fullname: SHANLEY JASON P – fullname: LIU DONG – fullname: SHEIKH AHMAD – fullname: GAI YONGHUA – fullname: SUN YING – fullname: GRIEME TIM – fullname: GRAMPOVNIK DAVID J – fullname: KU YIYIN – fullname: OR YAT SUN – fullname: ENGSTROM KEN – fullname: MCDANIEL KEITH F – fullname: WAGAW SEBLE H – fullname: MEI JIANZHANG – fullname: KEMPF DALE J – fullname: CHEN HUI-JU |
BookMark | eNrjYmDJy89L5WQw8k1MLspPrkzOyUxWyEgtSCzJLMksVnBWKE4tysxLVSgoyi9JTSxOVcjMy8hMyizJLyrmYWBNS8wpTuWF0twMym6uIc4euqkF-fGpxQWJyal5qSXxocFGBoYGhiYmZgYWjobGxKkCAJfXLvo |
ContentType | Patent |
DBID | EVB |
DatabaseName | esp@cenet |
DatabaseTitleList | |
Database_xml | – sequence: 1 dbid: EVB name: esp@cenet url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP sourceTypes: Open Access Repository |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Chemistry Sciences |
ExternalDocumentID | US2010144608A1 |
GroupedDBID | EVB |
ID | FETCH-epo_espacenet_US2010144608A13 |
IEDL.DBID | EVB |
IngestDate | Fri Jul 19 13:07:30 EDT 2024 |
IsOpenAccess | true |
IsPeerReviewed | false |
IsScholarly | false |
Language | English |
LinkModel | DirectLink |
MergedId | FETCHMERGED-epo_espacenet_US2010144608A13 |
Notes | Application Number: US20090584716 |
OpenAccessLink | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20100610&DB=EPODOC&CC=US&NR=2010144608A1 |
ParticipantIDs | epo_espacenet_US2010144608A1 |
PublicationCentury | 2000 |
PublicationDate | 20100610 |
PublicationDateYYYYMMDD | 2010-06-10 |
PublicationDate_xml | – month: 06 year: 2010 text: 20100610 day: 10 |
PublicationDecade | 2010 |
PublicationYear | 2010 |
Score | 2.7703447 |
Snippet | The present invention relates to novel macrocyclic compounds and methods of treating a hepatitis C infection in a subject in need of such therapy with said... |
SourceID | epo |
SourceType | Open Access Repository |
SubjectTerms | CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
Title | Macrocyclic hepatitis C serine protease inhibitors |
URI | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20100610&DB=EPODOC&locale=&CC=US&NR=2010144608A1 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3dS8MwED_GFPVNp-LHlIDSt2K79WsPRVzaMoRuw62yt5GmGSuMbtiK-N97iZ3uaW8hgcsl8LvL5b4AHheqcJaZ6sxFuFk90dV7jtfVPZu5LnNclipHezx0Bon1OrNnDVhtc2FUndAvVRwREcUR75WS15v_T6xAxVaWT2mOU-vnaOoHWm0dm1IjG1rQ98PxKBhRjVI_mWjDN7UmTR_De0Fb6QAf0q7EQ_jel3kpm12lEp3C4RjpFdUZNETRgmO67b3WgqO4dnnjsEZfeQ6dmKHY5N8ceSRLIWOhq7wklJQqh4-omguolUheLPM0l310LuAhCqd0oOPm87-zzpPJLqfdS2gW60JcATF45lhGxmxmydzRjPEFZyjKzI7JjJSJa2jvo3Szf_kWTn7d4g7K5TY0q49PcYfatkrv1SX9AI5Igow |
link.rule.ids | 230,309,783,888,25576,76876 |
linkProvider | European Patent Office |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3dS8NADA9jivNNp-J0akHpW7FdP_dQxPWDqms3XCt7K9ePsYJ0w1bE_97c2eme9nZc4C45-CWXyyUBuFuwwllSIhAd4aYMc1kYaoYsGCrRdaLpJGGBdj_QvEh5nqvzFrxvcmFYndAvVhwREZUi3mumr9f_j1g2-1tZ3ScFTq0e3NC0-cY7lqhFFnl7ZDrTiT2xeMsyoxkfvDIadX1E4xF9pT28ZOsUD87biOalrLeNinsE-1Ncr6yPoZWXXehYm95rXTjwm5A3Dhv0VScw8AmqzfQ7RR65ZU7_QtdFxVlcxXL4OFZzAa0SV5TLIiloH51TuHWd0PIE3Dz-kzWOZtucymfQLldlfg6cmGaaImZEJQrNHc1IukgJCiENJCImJO9Bf9dKF7vJN9DxQn8cj5-Cl0s4_A2Ra6ij-9CuPz7zK7S8dXLNDuwH2VWFfw |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=Macrocyclic+hepatitis+C+serine+protease+inhibitors&rft.inventor=SHANLEY+JASON+P&rft.inventor=LIU+DONG&rft.inventor=SHEIKH+AHMAD&rft.inventor=GAI+YONGHUA&rft.inventor=SUN+YING&rft.inventor=GRIEME+TIM&rft.inventor=GRAMPOVNIK+DAVID+J&rft.inventor=KU+YIYIN&rft.inventor=OR+YAT+SUN&rft.inventor=ENGSTROM+KEN&rft.inventor=MCDANIEL+KEITH+F&rft.inventor=WAGAW+SEBLE+H&rft.inventor=MEI+JIANZHANG&rft.inventor=KEMPF+DALE+J&rft.inventor=CHEN+HUI-JU&rft.date=2010-06-10&rft.externalDBID=A1&rft.externalDocID=US2010144608A1 |